Mechanisms of inherited neurodegenerative diseases
Mechanisms of inherited neurodegenerative diseases
批准号:
9563182
负责人:
Michael Ward
金额:
$118.17万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AdultAffectBiologyCell SurvivalCellsClinicalCollaborationsDehumanizationDevelopmentExhibitsFrontotemporal DementiaFunctional disorderGenesGoalsIndividualInheritedJournalsLysosomesManuscriptsMass Spectrum AnalysisMethodsModelingMolecularMusMutationNerve DegenerationNeurodegenerative DisordersNeuronsOrganellesPGRN genePathologicPatientsPhenotypePlant RootsPostdoctoral FellowPreclinical Drug EvaluationProcessProteinsProteomicsRecruitment ActivityReportingResearchRoleStem cellsTranslational Researchbaseeffective therapyexperimental studyhuman stem cellsprotein expressionsmall moleculetooltranslational medicineward
中文摘要
在上一财年,我们的项目取得了重大进展。我们在一本高质量的期刊上发表了一篇手稿(Ward等人,科学转化医学,2017),描述了与GRN突变个体溶酶体功能障碍相关的新的临床和病理表型。描述我们从人类干细胞产生大量神经元的新方法的第二份手稿最近被接受(Wang&Ward等人,Stem Cell报告)。我们开发了新的蛋白质组学方法来鉴定和量化溶酶体内蛋白质组成的变化,以及溶酶体与其他细胞器和胞浆蛋白的相互作用。在缺乏原颗粒的干细胞来源的神经元中使用这些工具,我们已经确定了几个蛋白质网络,它们在原颗粒缺乏的情况下表现出对溶酶体的募集减少。我们正在与Janelia的Jennifer Lippincott-Schwartz博士合作,通过假设驱动的实验来研究这些热门药物。此外,我们还扩大了我们的研究团队,通过招聘一名具有质谱学专业知识的博士后研究员,增强我们对干细胞神经元进行尖端蛋白质组分析的能力。最后,我们正在探索将我们的神经退行性疾病干细胞来源的神经元模型用于超高通量药物筛选的可能性,以确定新的细胞生存和异常表型的小分子调节因子,与NCATS联合使用。
英文摘要
We have made significant progress during the past fiscal year in our project. We one manuscript in a high quality journal (Ward et al, Science Translational Medicine, 2017) describing new clinical and pathological phenotypes related to lysosomal dysfunction in individuals with GRN mutations. A second manuscript describing our new method to generate large quantities of neurons from human stem cells was recently accepted (Wang & Ward et al, Stem Cell Reports). We have developed new proteomic methods to identify and quantify changes to the protein composition within lysosomes and interactions of lysosomes with other organelles and cytosolic proteins. Using these tools in stem cell derived neurons that lack progranulin, we have identified several networks of proteins that exhibit reduced recruitment to lysosomes in the setting of progranulin deficiency. We are in the process of investigating these hits with hypothesis-driven experiments in collaboration with Dr. Jennifer Lippincott-Schwartz at Janelia. Additionally, we have expanded our research team to enhance our ability to perform cutting-edge proteomic analysis of stem cell neurons by recruiting a post-doctoral fellow with expertise in mass spectrometry. Finally, we are exploring the possibility of using our stem cell derived neuronal models of neurodegenerative diseases for ultra-high throughput drug screens to identify new small molecule regulators of cell survival and abnormal phenotypes, in conjunction with NCATS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Increasing access to safe and effective products for the prevention, diagnosis and treatment of priority diseases, especially for use in low-and middle-income countries.
-
批准号:9351278
-
项目类别:
-
资助金额:$200.0万
-
财政年份:2016
-
负责人:Michael Ward
-
依托单位:
Outcomes in Rheumatic Diseases
-
批准号:8559298
-
项目类别:
-
资助金额:$107.83万
-
财政年份:--
-
负责人:Michael Ward
-
依托单位:
Outcomes in Rheumatic Diseases
-
批准号:8939424
-
项目类别:
-
资助金额:$146.57万
-
财政年份:--
-
负责人:Michael Ward
-
依托单位:
Mechanisms of inherited neurodegenerative diseases
-
批准号:10265225
-
项目类别:
-
资助金额:$368.37万
-
财政年份:--
-
负责人:Michael Ward
-
依托单位:
Rheumatic and Autoimmune Diseases in Minority Communities
-
批准号:8559307
-
项目类别:
-
资助金额:$43.59万
-
财政年份:--
-
负责人:Michael Ward
-
依托单位:
Outcomes in Rheumatic Diseases
-
批准号:8746504
-
项目类别:
-
资助金额:$103.5万
-
财政年份:--
-
负责人:Michael Ward
-
依托单位:
Rheumatic and Autoimmune Diseases in Minority Communities
-
批准号:9155475
-
项目类别:
-
资助金额:$85.99万
-
财政年份:--
-
负责人:Michael Ward
-
依托单位:
Mechanisms of inherited neurodegenerative diseases
-
批准号:10708629
-
项目类别:
-
资助金额:$273.52万
-
财政年份:--
-
负责人:Michael Ward
-
依托单位:
Outcomes in Rheumatic Diseases
-
批准号:10265851
-
项目类别:
-
资助金额:$67.76万
-
财政年份:--
-
负责人:Michael Ward
-
依托单位:
Rheumatic and Autoimmune Diseases in Minority Communities
-
批准号:10265854
-
项目类别:
-
资助金额:$37.37万
-
财政年份:--
-
负责人:Michael Ward
-
依托单位:
Rheumatic and Autoimmune Diseases in Minority Communities
-
批准号:8175281
-
项目类别:
-
资助金额:$41.48万
-
财政年份:--
-
负责人:Michael Ward
-
依托单位:
Rheumatic and Autoimmune Diseases in Minority Communities
-
批准号:8746513
-
项目类别:
-
资助金额:$45.74万
-
财政年份:--
-
负责人:Michael Ward
-
依托单位:
Rheumatic and Autoimmune Diseases in Minority Communities
-
批准号:8344728
-
项目类别:
-
资助金额:$35.9万
-
财政年份:--
-
负责人:Michael Ward
-
依托单位:
Outcomes in Rheumatic Diseases
-
批准号:9563897
-
项目类别:
-
资助金额:$99.3万
-
财政年份:--
-
负责人:Michael Ward
-
依托单位:
Rheumatic and Autoimmune Diseases in Minority Communities
-
批准号:7964954
-
项目类别:
-
资助金额:$31.19万
-
财政年份:--
-
负责人:Michael Ward
-
依托单位:
Rheumatic and Autoimmune Diseases in Minority Communities
-
批准号:10709757
-
项目类别:
-
资助金额:$68.7万
-
财政年份:--
-
负责人:Michael Ward
-
依托单位:
Mechanisms of inherited neurodegenerative diseases
-
批准号:9358619
-
项目类别:
-
资助金额:$108.55万
-
财政年份:--
-
负责人:Michael Ward
-
依托单位:
Outcomes in Rheumatic Diseases
-
批准号:8175279
-
项目类别:
-
资助金额:$109.2万
-
财政年份:--
-
负责人:Michael Ward
-
依托单位:
Outcomes in Rheumatic Diseases
-
批准号:7964936
-
项目类别:
-
资助金额:$96.59万
-
财政年份:--
-
负责人:Michael Ward
-
依托单位:
Outcomes in Rheumatic Diseases
-
批准号:8344719
-
项目类别:
-
资助金额:$96.65万
-
财政年份:--
-
负责人:Michael Ward
-
依托单位:
海外基金